Regulatory Insights: The Future of MedTech and Pharma Under the New AdministrationRegulatory Insights: The Future of MedTech and Pharma Under the New Administration

The new US Presidential Administration could bring significant impact on MedTech and pharmaceutical regulations for manufacturers and product developers. Join our expert panel of scientists and FDA consultants as they explore the potential regulatory changes. Speakers will discuss changes in several key areas, including FDA policy shifts, warning and consent letters, vaccine regulation, Artificial Intelligence in healthcare, and the supply chain.

These experts will share firsthand knowledge of ongoing discussions and emerging trends, and help you prepare changes that will shape the future of the healthcare industry.